{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T08:44:44Z","timestamp":1761554684412,"version":"build-2065373602"},"reference-count":126,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100011272","name":"FP7 Health","doi-asserted-by":"publisher","award":["2010 261409"],"award-info":[{"award-number":["2010 261409"]}],"id":[{"id":"10.13039\/100011272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","award":["RP\/2007\/313"],"award-info":[{"award-number":["RP\/2007\/313"]}],"id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.hfc.2011.11.006","type":"journal-article","created":{"date-parts":[[2011,12,28]],"date-time":"2011-12-28T07:36:33Z","timestamp":1325057793000},"page":"225-236","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["The Role of Renin Angiotensin System Intervention in Stage B Heart Failure"],"prefix":"10.1016","volume":"8","author":[{"given":"Patrick","family":"Collier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth M.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.hfc.2011.11.006_bib1","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJM198606123142404","article-title":"Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study","volume":"314","author":"Cohn","year":"1986","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.hfc.2011.11.006_bib2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijcard.2010.04.055","article-title":"Incidence and mortality of heart failure: a community-based study","volume":"151","author":"Gomez-Soto","year":"2011","journal-title":"Int J Cardiol"},{"issue":"12","key":"10.1016\/j.hfc.2011.11.006_bib3","first-page":"e154","volume":"112","author":"Hunt","year":"2005","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.hfc.2011.11.006_bib4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1161\/01.HYP.24.1.37","article-title":"Cardiac renin and angiotensins. Uptake from plasma versus in situ synthesis","volume":"24","author":"Danser","year":"1994","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.hfc.2011.11.006_bib5","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1172\/JCI119529","article-title":"Compartmentalization of angiotensin II generation in the dog heart. Evidence for independent mechanisms in intravascular and interstitial spaces","volume":"100","author":"Dell\u2019Italia","year":"1997","journal-title":"J\u00a0Clin Invest"},{"issue":"7","key":"10.1016\/j.hfc.2011.11.006_bib6","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/01.RES.85.7.643","article-title":"The cardiac renin-angiotensin system: conceptual, or a regulator of cardiac function?","volume":"85","author":"Dostal","year":"1999","journal-title":"Circ Res"},{"issue":"4 Pt 2","key":"10.1016\/j.hfc.2011.11.006_bib7","first-page":"H1769","article-title":"Angiotensin II formation from ACE and chymase in human and animal hearts: methods and species considerations","volume":"273","author":"Balcells","year":"1997","journal-title":"Am J Physiol"},{"issue":"1\u20133","key":"10.1016\/j.hfc.2011.11.006_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-0115(99)00123-8","article-title":"The cardiac renin-angiotensin system: novel signaling mechanisms related to cardiac growth and function","volume":"91","author":"Dostal","year":"2000","journal-title":"Regul Pept"},{"issue":"5","key":"10.1016\/j.hfc.2011.11.006_bib9","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0735-1097(01)01539-X","article-title":"Relationship between transcardiac extraction of aldosterone and left ventricular remodeling in patients with first acute myocardial infarction: extracting aldosterone through the heart promotes ventricular remodeling after acute myocardial infarction","volume":"38","author":"Hayashi","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.hfc.2011.11.006_bib10","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1093\/cvr\/28.9.1423","article-title":"Cardiac angiotensin converting enzyme and myocardial fibrosis in the rat","volume":"28","author":"Sun","year":"1994","journal-title":"Cardiovasc Res"},{"issue":"4","key":"10.1016\/j.hfc.2011.11.006_bib11","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0735-1097(99)00316-2","article-title":"Improvement of myocardial blood flow to ischemic regions by angiotensin-converting enzyme inhibition with quinaprilat IV: a study using [15O] water dobutamine stress positron emission tomography","volume":"34","author":"Schneider","year":"1999","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.hfc.2011.11.006_bib12","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0022-2828(87)80619-3","article-title":"Protective effects of captopril and enalapril on myocardial ischemia and reperfusion damage of rat","volume":"19","author":"Li","year":"1987","journal-title":"J\u00a0Mol Cell Cardiol"},{"issue":"3","key":"10.1016\/j.hfc.2011.11.006_bib13","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1161\/01.CIR.94.3.258","article-title":"Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing Endothelial Dysfunction) Study","volume":"94","author":"Mancini","year":"1996","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.hfc.2011.11.006_bib14","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1161\/01.CIR.93.3.544","article-title":"Angiotensin-converting enzyme inhibition preserves endothelium-dependent coronary microvascular responses during short-term ischemia-reperfusion","volume":"93","author":"Piana","year":"1996","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.hfc.2011.11.006_bib15","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0735-1097(99)00318-6","article-title":"Angiotensin-converting enzyme inhibition reduces monocyte chemoattractant protein-1 and tissue factor levels in patients with myocardial infarction","volume":"34","author":"Soejima","year":"1999","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.hfc.2011.11.006_bib16","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S1357-2725(02)00271-6","article-title":"Inflammation and angiotensin II","volume":"35","author":"Suzuki","year":"2003","journal-title":"Int J Biochem Cell Biol"},{"issue":"5","key":"10.1016\/j.hfc.2011.11.006_bib17","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1161\/01.HYP.25.5.913","article-title":"Angiotensin II increases vascular permeability factor gene expression by human vascular smooth muscle cells","volume":"25","author":"Williams","year":"1995","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.hfc.2011.11.006_bib18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00041552-200105000-00005","article-title":"Proinflammatory actions of angiotensins","volume":"10","author":"Ruiz-Ortega","year":"2001","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"1","key":"10.1016\/j.hfc.2011.11.006_bib19","doi-asserted-by":"crossref","first-page":"H107","DOI":"10.1152\/ajpheart.00763.2003","article-title":"Influence of cytokines and growth factors in ANG II-mediated collagen upregulation by fibroblasts in rats: role of myocytes","volume":"287","author":"Sarkar","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"12","key":"10.1016\/j.hfc.2011.11.006_bib20","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1161\/01.CIR.0000089129.51288.BA","article-title":"Connective tissue growth factor is a mediator of angiotensin II-induced fibrosis","volume":"108","author":"Ruperez","year":"2003","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.hfc.2011.11.006_bib21","doi-asserted-by":"crossref","first-page":"H635","DOI":"10.1152\/ajpheart.00986.2001","article-title":"ANG II increases TIMP-1 expression in rat aortic smooth muscle cells in\u00a0vivo","volume":"284","author":"Castoldi","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"10.1016\/j.hfc.2011.11.006_bib22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1006\/jmcc.1993.1017","article-title":"Selective activation of cardiac angiotensinogen gene expression in post-infarction ventricular remodeling in the rat","volume":"25","author":"Lindpaintner","year":"1993","journal-title":"J\u00a0Mol Cell Cardiol"},{"issue":"23","key":"10.1016\/j.hfc.2011.11.006_bib23","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1161\/01.CIR.97.23.2359","article-title":"Dual-tracer assessment of coupling between cardiac sympathetic neuronal function and downregulation of beta-receptors during development of hypertensive heart failure of rats","volume":"97","author":"Nozawa","year":"1998","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.hfc.2011.11.006_bib24","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1161\/01.CIR.101.25.2981","article-title":"Left ventricular remodeling after myocardial infarction: pathophysiology and therapy","volume":"101","author":"Sutton","year":"2000","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.hfc.2011.11.006_bib25","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1161\/01.CIR.96.2.442","article-title":"Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction. HEART Study Investigators","volume":"96","author":"Vaughan","year":"1997","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.hfc.2011.11.006_bib26","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0735-1097(01)01202-5","article-title":"Bradykinin stimulates the release of tissue plasminogen activator in human coronary circulation: effects of angiotensin-converting enzyme inhibitors","volume":"37","author":"Minai","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.hfc.2011.11.006_bib27","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1161\/01.CIR.101.12.1372","article-title":"Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability","volume":"101","author":"Schieffer","year":"2000","journal-title":"Circulation"},{"issue":"Suppl 1","key":"10.1016\/j.hfc.2011.11.006_bib28","first-page":"99","article-title":"Renin subgroups in essential hypertension. Further analysis of their pathophysiological and epidemiological characteristics","volume":"32","author":"Brunner","year":"1973","journal-title":"Circ Res"},{"issue":"6","key":"10.1016\/j.hfc.2011.11.006_bib29","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1097\/00004872-198900076-00023","article-title":"Central haemodynamics in essential hypertension at rest and during exercise: a 20-year follow-up study","volume":"7","author":"Lund-Johansen","year":"1989","journal-title":"J\u00a0Hypertens Suppl"},{"issue":"10","key":"10.1016\/j.hfc.2011.11.006_bib30","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1172\/JCI5056","article-title":"Communication between myocytes and fibroblasts in cardiac remodeling in angiotensin chimeric mice","volume":"103","author":"Matsusaka","year":"1999","journal-title":"J\u00a0Clin Invest"},{"issue":"23","key":"10.1016\/j.hfc.2011.11.006_bib31","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1161\/01.CIR.98.23.2553","article-title":"Expression of functional angiotensin-converting enzyme and AT1 receptors in cultured human cardiac fibroblasts","volume":"98","author":"Hafizi","year":"1998","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.hfc.2011.11.006_bib32","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1161\/01.CIR.98.24.2765","article-title":"Differential effects of angiotensin II on cardiac cell proliferation and intramyocardial perivascular fibrosis in\u00a0vivo","volume":"98","author":"McEwan","year":"1998","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.hfc.2011.11.006_bib33","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1161\/01.CIR.101.10.1130","article-title":"Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts","volume":"101","author":"Kawano","year":"2000","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.hfc.2011.11.006_bib34","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1161\/01.RES.73.3.413","article-title":"Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype","volume":"73","author":"Sadoshima","year":"1993","journal-title":"Circ Res"},{"issue":"1\u20133","key":"10.1016\/j.hfc.2011.11.006_bib35","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.regpep.2004.04.004","article-title":"Evidence of a novel intracrine mechanism in angiotensin II-induced cardiac hypertrophy","volume":"120","author":"Baker","year":"2004","journal-title":"Regul Pept"},{"issue":"6","key":"10.1016\/j.hfc.2011.11.006_bib36","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1161\/01.HYP.31.6.1324","article-title":"Blood pressure-independent cardiac hypertrophy induced by locally activated renin-angiotensin system","volume":"31","author":"Mazzolai","year":"1998","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.hfc.2011.11.006_bib37","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1073\/pnas.97.2.931","article-title":"Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling","volume":"97","author":"Paradis","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"20","key":"10.1016\/j.hfc.2011.11.006_bib38","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1161\/01.CIR.100.20.2093","article-title":"Angiotensin II type 1A receptor knockout mice display less left ventricular remodeling and improved survival after myocardial infarction","volume":"100","author":"Harada","year":"1999","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.hfc.2011.11.006_bib39","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1161\/01.CIR.93.6.1148","article-title":"Plasma angiotensin II, predisposition to hypertension, and left ventricular size in healthy young adults","volume":"93","author":"Harrap","year":"1996","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.hfc.2011.11.006_bib40","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1161\/01.CIR.90.1.179","article-title":"Impact of left ventricular structure on the incidence of hypertension. The Framingham Heart Study","volume":"90","author":"Post","year":"1994","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.hfc.2011.11.006_bib41","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1161\/01.HYP.7.2.171","article-title":"What is the role of ambulatory blood pressure monitoring in the management of hypertensive patients?","volume":"7","author":"Pickering","year":"1985","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.hfc.2011.11.006_bib42","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/0092-8674(93)90541-W","article-title":"Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in\u00a0vitro","volume":"75","author":"Sadoshima","year":"1993","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.hfc.2011.11.006_bib43","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/hr.2009.43","article-title":"Diabetes mellitus accelerates left ventricular diastolic dysfunction through activation of the renin-angiotensin system in hypertensive rats","volume":"32","author":"Fukui","year":"2009","journal-title":"Hypertens Res"},{"issue":"5","key":"10.1016\/j.hfc.2011.11.006_bib44","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.ahj.2004.04.019","article-title":"Effects of diabetes mellitus and ischemic heart disease on the progression from asymptomatic left ventricular dysfunction to symptomatic heart failure: a retrospective analysis from the Studies of Left Ventricular Dysfunction (SOLVD) Prevention trial","volume":"148","author":"Das","year":"2004","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.hfc.2011.11.006_bib45","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/labinvest.3780057","article-title":"Myocyte death in\u00a0streptozotocin-induced diabetes in rats in angiotensin II- dependent","volume":"80","author":"Fiordaliso","year":"2000","journal-title":"Lab Invest"},{"issue":"11","key":"10.1016\/j.hfc.2011.11.006_bib46","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1161\/01.CIR.96.11.4065","article-title":"Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation","volume":"96","author":"Weber","year":"1997","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.hfc.2011.11.006_bib47","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1161\/hc0302.103712","article-title":"Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice","volume":"105","author":"Bendall","year":"2002","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.hfc.2011.11.006_bib48","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1378\/chest.121.5.1638","article-title":"Alcoholic cardiomyopathy: incidence, clinical characteristics, and pathophysiology","volume":"121","author":"Piano","year":"2002","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.hfc.2011.11.006_bib49","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1530-0277.2001.tb02235.x","article-title":"A\u00a0rodent model of alcoholic heart muscle disease and its evaluation by echocardiography","volume":"25","author":"Kim","year":"2001","journal-title":"Alcohol Clin Exp Res"},{"issue":"2","key":"10.1016\/j.hfc.2011.11.006_bib50","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1530-0277.1992.tb01368.x","article-title":"Neuroendocrine, fluid balance, and thirst responses to alcohol in alcoholics","volume":"16","author":"Collins","year":"1992","journal-title":"Alcohol Clin Exp Res"},{"issue":"5 Part 1","key":"10.1016\/j.hfc.2011.11.006_bib51","doi-asserted-by":"crossref","first-page":"321","DOI":"10.7326\/0003-4819-137-5_Part_1-200209030-00007","article-title":"Angiotensin-converting enzyme gene polymorphism is associated with vulnerability to lcoholic\u00a0cardiomyopathy","volume":"137","author":"Fernandez-Sola","year":"2002","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.hfc.2011.11.006_bib52","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/01.CIR.92.6.1387","article-title":"Angiotensin-converting enzyme in the human heart. Effect of the deletion\/insertion polymorphism","volume":"92","author":"Danser","year":"1995","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.hfc.2011.11.006_bib53","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1046\/j.1540-8167.2004.03609.x","article-title":"Interaction of implantable defibrillator therapy with angiotensin-converting enzyme deletion\/insertion polymorphism","volume":"15","author":"Bedi","year":"2004","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"issue":"4","key":"10.1016\/j.hfc.2011.11.006_bib54","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1291\/hypres.25.597","article-title":"Angiotensin II type 1a receptor mediates doxorubicin-induced cardiomyopathy","volume":"25","author":"Toko","year":"2002","journal-title":"Hypertens Res"},{"issue":"11","key":"10.1016\/j.hfc.2011.11.006_bib55","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1016\/j.jacc.2003.07.021","article-title":"Attenuation of virus-induced myocardial injury by inhibition of the angiotensin II type 1 receptor signal and decreased nuclear factor-kappa B activation in knockout mice","volume":"42","author":"Yamamoto","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.hfc.2011.11.006_bib56","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1042\/cs1030623","article-title":"Time course of gene expression in rat experimental autoimmune myocarditis","volume":"103","author":"Hanawa","year":"2002","journal-title":"Clin Sci (Lond)"},{"issue":"14","key":"10.1016\/j.hfc.2011.11.006_bib57","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1161\/01.CIR.97.14.1411","article-title":"Angiotensin-converting enzyme inhibitors","volume":"97","author":"Brown","year":"1998","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.hfc.2011.11.006_bib58","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1161\/01.CIR.95.5.1115","article-title":"Role of bradykinin in\u00a0mediating vascular effects of angiotensin-converting enzyme inhibitors in humans","volume":"95","author":"Hornig","year":"1997","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.hfc.2011.11.006_bib59","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1161\/01.CIR.0000046268.59922.A4","article-title":"Angiotensin-converting enzyme inhibition increases human vascular tissue-type plasminogen activator release through endogenous bradykinin","volume":"107","author":"Pretorius","year":"2003","journal-title":"Circulation"},{"issue":"9204","key":"10.1016\/j.hfc.2011.11.006_bib60","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0140-6736(99)10365-9","article-title":"Angiotensin II receptor antagonists","volume":"355","author":"Burnier","year":"2000","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.hfc.2011.11.006_bib61","doi-asserted-by":"crossref","first-page":"234","DOI":"10.7326\/0003-4819-117-3-234","article-title":"Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology","volume":"117","author":"Israili","year":"1992","journal-title":"Ann Intern Med"},{"issue":"3 Pt 2","key":"10.1016\/j.hfc.2011.11.006_bib62","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1161\/01.HYP.27.3.760","article-title":"Opposing actions of\u00a0angiotensin II on microvascular growth and arterial blood pressure","volume":"27","author":"Munzenmaier","year":"1996","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.hfc.2011.11.006_bib63","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/clc.4960200103","article-title":"Angiotensin-II-receptors: new targets for antihypertensive therapy","volume":"20","author":"Oliverio","year":"1997","journal-title":"Clin Cardiol"},{"issue":"1","key":"10.1016\/j.hfc.2011.11.006_bib64","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/01.RES.57.1.84","article-title":"Influence of chronic captopril therapy on the infarcted left ventricle of the rat","volume":"57","author":"Pfeffer","year":"1985","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.hfc.2011.11.006_bib65","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1056\/NEJM198807143190204","article-title":"Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction","volume":"319","author":"Pfeffer","year":"1988","journal-title":"N\u00a0Engl J Med"},{"issue":"17","key":"10.1016\/j.hfc.2011.11.006_bib66","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/0002-9149(89)90173-2","article-title":"Effects of left ventricular shape and captopril therapy on exercise capacity after anterior wall acute myocardial infarction","volume":"63","author":"Lamas","year":"1989","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.1016\/j.hfc.2011.11.006_bib67","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1161\/01.CIR.94.7.1513","article-title":"Expression of angiotensin-converting enzyme in remaining viable myocytes of human ventricles after myocardial infarction","volume":"94","author":"Hokimoto","year":"1996","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.hfc.2011.11.006_bib68","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1161\/01.CIR.95.12.2607","article-title":"Plasma angiotensin-converting enzyme activity and left ventricular dilation after myocardial infarction","volume":"95","author":"Oosterga","year":"1997","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.hfc.2011.11.006_bib69","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/heart.83.1.76","article-title":"Postinfarction left ventricular remodelling: where are the theories and trials leading us?","volume":"83","author":"Yousef","year":"2000","journal-title":"Heart"},{"issue":"3","key":"10.1016\/j.hfc.2011.11.006_bib70","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0735-1097(98)00609-3","article-title":"Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction. A meta-analysis of randomized clinical trials","volume":"33","author":"Domanski","year":"1999","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.hfc.2011.11.006_bib71","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0002-9149(00)01209-1","article-title":"Effect of angiotensin-converting enzyme inhibitor on cardiopulmonary baroreflex sensitivity in patients with acute myocardial infarction","volume":"86","author":"Hikosaka","year":"2000","journal-title":"Am J Cardiol"},{"issue":"8","key":"10.1016\/j.hfc.2011.11.006_bib72","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1161\/01.ATV.0000021412.56621.A2","article-title":"Vascular inflammation and the renin-angiotensin system","volume":"22","author":"Brasier","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.hfc.2011.11.006_bib73","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0021-9150(97)00254-2","article-title":"Delapril slows the progression of atherosclerosis and maintains endothelial function in cholesterol-fed rabbits","volume":"137","author":"Hernandez","year":"1998","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.hfc.2011.11.006_bib74","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/00005344-199804000-00011","article-title":"Antiatherosclerotic and antioxidative effects of captopril in apolipoprotein E-deficient mice","volume":"31","author":"Hayek","year":"1998","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"issue":"3","key":"10.1016\/j.hfc.2011.11.006_bib75","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0008-6363(99)00239-4","article-title":"The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice","volume":"44","author":"Hayek","year":"1999","journal-title":"Cardiovasc Res"},{"issue":"7","key":"10.1016\/j.hfc.2011.11.006_bib76","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1161\/01.CIR.103.7.919","article-title":"Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE)","volume":"103","author":"Lonn","year":"2001","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.hfc.2011.11.006_bib77","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0735-1097(00)00736-1","article-title":"Randomized, placebo-controlled trial of the angiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease. PART-2 Collaborative Research Group. Prevention of atherosclerosis with ramipril","volume":"36","author":"MacMahon","year":"2000","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.hfc.2011.11.006_bib78","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.hfc.2011.11.006_bib79","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199209033271003","article-title":"Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigators","volume":"327","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.hfc.2011.11.006_bib80","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1161\/01.CIR.91.10.2573","article-title":"Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy","volume":"91","author":"Greenberg","year":"1995","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.hfc.2011.11.006_bib81","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJM199512213332503","article-title":"A\u00a0clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group","volume":"333","author":"Kober","year":"1995","journal-title":"N\u00a0Engl J Med"},{"issue":"9172","key":"10.1016\/j.hfc.2011.11.006_bib82","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)09374-X","article-title":"Effect of ACE inhibitor trandolapril on life expectancy of patients with reduced left-ventricular function after acute myocardial infarction. TRACE Study Group. Trandolapril cardiac evaluation","volume":"354","author":"Torp-Pedersen","year":"1999","journal-title":"Lancet"},{"issue":"8951","key":"10.1016\/j.hfc.2011.11.006_bib83","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0140-6736(95)90865-X","volume":"345","year":"1995","journal-title":"Lancet"},{"issue":"8906","key":"10.1016\/j.hfc.2011.11.006_bib84","first-page":"1115","article-title":"GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell\u2019infarto Miocardico","volume":"343","year":"1994","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.hfc.2011.11.006_bib85","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1161\/01.CIR.99.9.1127","article-title":"Meeting highlights. Highlights of the 20th congress of the European Society of Cardiology","volume":"99","author":"Ferguson","year":"1999","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.hfc.2011.11.006_bib86","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1161\/01.CIR.97.22.2202","article-title":"Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group","volume":"97","year":"1998","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.hfc.2011.11.006_bib87","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jacc.2007.10.001","article-title":"2007 focused update of the ACC\/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"51","author":"Antman","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.hfc.2011.11.006_bib88","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1161\/01.CIR.92.10.3132","article-title":"ACE inhibitor use in patients with myocardial infarction. Summary of evidence from clinical trials","volume":"92","author":"Latini","year":"1995","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.hfc.2011.11.006_bib89","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0002-9149(99)80223-9","article-title":"Effect of early enalapril therapy on left ventricular function and structure in acute myocardial infarction","volume":"76","author":"Schulman","year":"1995","journal-title":"Am J Cardiol"},{"issue":"8875","key":"10.1016\/j.hfc.2011.11.006_bib90","first-page":"821","article-title":"Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators","volume":"342","year":"1993","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.hfc.2011.11.006_bib91","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1056\/NEJM199501123320203","article-title":"The effect of\u00a0the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators","volume":"332","author":"Ambrosioni","year":"1995","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.hfc.2011.11.006_bib92","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7326\/0003-4819-141-2-200407200-00016","article-title":"Is improved survival a class effect of angiotensin-converting enzyme inhibitors?","volume":"141","author":"Hennessy","year":"2004","journal-title":"Ann Intern Med"},{"issue":"23","key":"10.1016\/j.hfc.2011.11.006_bib93","first-page":"1429","article-title":"Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group","volume":"316","year":"1987","journal-title":"N\u00a0Engl J Med"},{"issue":"17","key":"10.1016\/j.hfc.2011.11.006_bib94","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1001\/archinte.160.17.2645","article-title":"Are we inhibited? Renal insufficiency should not preclude the use of ACE inhibitors for patients with myocardial infarction and depressed left ventricular function","volume":"160","author":"Frances","year":"2000","journal-title":"Arch Intern Med"},{"issue":"9335","key":"10.1016\/j.hfc.2011.11.006_bib95","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(02)09895-1","article-title":"Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan","volume":"360","author":"Dickstein","year":"2002","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.hfc.2011.11.006_bib96","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa032292","article-title":"Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both","volume":"349","author":"Pfeffer","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.hfc.2011.11.006_bib97","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1073\/pnas.79.10.3310","article-title":"Regression of left ventricular hypertrophy and prevention of left\u00a0ventricular dysfunction by captopril in thespontaneously hypertensive rat","volume":"79","author":"Pfeffer","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.hfc.2011.11.006_bib98","first-page":"977","article-title":"Alterations in the electrocardiogram of spontaneously hypertensive rats by chronic antihypertensive therapy with captopril","volume":"4","author":"Kleber","year":"1982","journal-title":"Clin Exp Hypertens A"},{"issue":"9215","key":"10.1016\/j.hfc.2011.11.006_bib99","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(00)02212-1","article-title":"Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group","volume":"355","author":"Flather","year":"2000","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.hfc.2011.11.006_bib100","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators","volume":"342","author":"Yusuf","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"9386","key":"10.1016\/j.hfc.2011.11.006_bib101","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0140-6736(03)14286-9","article-title":"Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)","volume":"362","author":"Fox","year":"2003","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.hfc.2011.11.006_bib102","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1161\/01.CIR.96.9.3164","article-title":"Long-term ACE inhibition doubles lifespan of hypertensive rats","volume":"96","author":"Linz","year":"1997","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.hfc.2011.11.006_bib103","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1161\/01.CIR.90.4.2056","article-title":"Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection","volume":"90","author":"Lonn","year":"1994","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.hfc.2011.11.006_bib104","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1161\/01.HYP.18.2.148","article-title":"Enalapril prevents cardiac fibrosis and arrhythmias in hypertensive rats","volume":"18","author":"Pahor","year":"1991","journal-title":"Hypertension"},{"issue":"7A","key":"10.1016\/j.hfc.2011.11.006_bib105","doi-asserted-by":"crossref","first-page":"19i","DOI":"10.1016\/S0002-9149(01)01918-X","article-title":"Perindopril treatment for congestive heart failure","volume":"88","author":"Sonnenblick","year":"2001","journal-title":"Am J Cardiol"},{"issue":"12","key":"10.1016\/j.hfc.2011.11.006_bib106","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1161\/01.CIR.102.12.1388","article-title":"Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease","volume":"102","author":"Brilla","year":"2000","journal-title":"Circulation"},{"issue":"9311","key":"10.1016\/j.hfc.2011.11.006_bib107","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","article-title":"Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint Reduction in\u00a0Hypertension Study (LIFE): a randomised trial against atenolol","volume":"359","author":"Dahlof","year":"2002","journal-title":"Lancet"},{"issue":"9386","key":"10.1016\/j.hfc.2011.11.006_bib108","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of\u00a0candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.hfc.2011.11.006_bib109","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1161\/01.CIR.0000017264.66561.3D","article-title":"Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients","volume":"105","author":"Diez","year":"2002","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.hfc.2011.11.006_bib110","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1161\/01.HYP.35.6.1197","article-title":"Chronic AT(1) blockade stimulates extracellular collagen type I degradation and reverses myocardial fibrosis in spontaneously hypertensive rats","volume":"35","author":"Varo","year":"2000","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.hfc.2011.11.006_bib111","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1161\/HYPERTENSIONAHA.109.129353","article-title":"Losartan metabolite EXP3179 blocks NADPH oxidase-mediated superoxide production by inhibiting protein kinase C: potential clinical implications in hypertension","volume":"54","author":"Fortuno","year":"2009","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.hfc.2011.11.006_bib112","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1161\/hy0102.100788","article-title":"Stimulation of cardiac apoptosis in essential hypertension: potential role of angiotensin II","volume":"39","author":"Gonzalez","year":"2002","journal-title":"Hypertension"},{"issue":"14","key":"10.1016\/j.hfc.2011.11.006_bib113","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.hfc.2011.11.006_bib114","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.hfc.2011.11.006_bib115","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1161\/01.HYP.0000203732.03784.3b","article-title":"Mineralocorticoid receptors and cardiovascular damage: it\u2019s not just aldosterone","volume":"47","author":"Funder","year":"2006","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.hfc.2011.11.006_bib116","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1210\/jc.2003-032149","article-title":"Distinguishing the antihypertensive and electrolyte effects of eplerenone","volume":"89","author":"Levy","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.hfc.2011.11.006_bib117","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/S0735-1097(03)00054-8","article-title":"Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients","volume":"41","author":"Flack","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.hfc.2011.11.006_bib118","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1210\/en.2004-0005","article-title":"Eplerenone, but not steroid withdrawal, reverses cardiac fibrosis in deoxycorticosterone\/salt-treated rats","volume":"145","author":"Young","year":"2004","journal-title":"Endocrinology"},{"issue":"15","key":"10.1016\/j.hfc.2011.11.006_bib119","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1161\/01.CIR.0000091405.00772.6E","article-title":"Effects of eplerenone, enalapril, and eplerenone\/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study","volume":"108","author":"Pitt","year":"2003","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.hfc.2011.11.006_bib120","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.jacc.2009.08.021","article-title":"Natural history of markers of collagen turnover in patients with early diastolic dysfunction and impact of eplerenone","volume":"54","author":"Mak","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.hfc.2011.11.006_bib121","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0002-9343(03)00158-X","article-title":"A\u00a0meta-analysis of the effects of treatment on left ventricular mass in essential hypertension","volume":"115","author":"Klingbeil","year":"2003","journal-title":"Am J Med"},{"issue":"9","key":"10.1016\/j.hfc.2011.11.006_bib122","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1161\/01.CIR.0000054611.89228.92","article-title":"Enalapril reduces the incidence of diabetes in patients with chronic heart failure: insight from the Studies Of Left Ventricular Dysfunction (SOLVD)","volume":"107","author":"Vermes","year":"2003","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.hfc.2011.11.006_bib123","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2337\/diacare.23.3.377","article-title":"Enalapril prevents clinical proteinuria in diabetic patients with low ejection fraction","volume":"23","author":"Capes","year":"2000","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.hfc.2011.11.006_bib124","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1161\/CIRCULATIONAHA.105.596494","article-title":"Angiotensin II type 1 receptor blockade prevents alcoholic cardiomyopathy","volume":"114","author":"Cheng","year":"2006","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.hfc.2011.11.006_bib125","doi-asserted-by":"crossref","first-page":"487.e1","DOI":"10.1016\/j.ahj.2010.05.037","article-title":"Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment","volume":"160","author":"Cadeddu","year":"2010","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.hfc.2011.11.006_bib126","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/eurjhf\/hfp023","article-title":"Anti-inflammatory effects of eplerenone on viral myocarditis","volume":"11","author":"Xiao","year":"2009","journal-title":"Eur J Heart Fail"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713611001334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713611001334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T08:38:12Z","timestamp":1761554292000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551713611001334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":126,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S1551713611001334"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2011.11.006","relation":{},"ISSN":["1551-7136"],"issn-type":[{"type":"print","value":"1551-7136"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of Renin Angiotensin System Intervention in Stage B Heart Failure","name":"articletitle","label":"Article Title"},{"value":"Heart Failure Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hfc.2011.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}